Your browser doesn't support javascript.
loading
Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
Chakhachiro, Zaher I; Saliba, Rima M; Okoroji, Grace-Julia; Korbling, Martin; Alousi, Amin M; Betul, Oran; Anderlini, Paolo; Ciurea, Stefan O; Popat, Uday; Champlin, Richard; Samuels, Barry I; Medeiros, L Jeffrey; Bueso-Ramos, Carlos; Khouri, Issa F.
Affiliation
  • Chakhachiro ZI; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 119(18): 3318-25, 2013 Sep 15.
Article in En | MEDLINE | ID: mdl-23775587
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Ki-67 Antigen / Transplantation Conditioning / Lymphoma, Mantle-Cell / Stem Cell Transplantation / SOXC Transcription Factors Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2013 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Ki-67 Antigen / Transplantation Conditioning / Lymphoma, Mantle-Cell / Stem Cell Transplantation / SOXC Transcription Factors Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2013 Document type: Article Country of publication: United States